E Prescribing Market - Global Industry Dynamics & Future Forecasts

By -

The E-prescribing Solutions Segment Accounted for Largest Share of the Market, While the E-prescribing Services Segment Is Expected to Register a High Growth Rate

(EMAILWIRE.COM, February 06, 2019 ) The global E Prescribing Market is projected to grow at a CAGR of 20.8% during the forecast period. Various government initiatives and incentive programs, rising focus on the reduction of fraud & abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail escalating healthcare costs are the major factors driving the growth of the global e-prescribing market.

On the basis of product, the e-prescribing services segment is expected to witness the highest growth during the forecast period. The high growth rate of the e-prescribing services segment can be attributed to the increasing adoption of e-prescribing that lead to a growing demand for training & education services; stringent regulations that have increased the application of implementation services for the validation & verification of hardware & software; and the need for frequent support and maintenance.

Based on delivery mode, the web & cloud-based segment is expected to dominate the market, with the highest growth rate during the forecast period.

Read More Details | Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=910

This growth of web & cloud-based segment can be primarily attributed to the improved performance and reliability by avoiding long deployment cycles, minimized upfront investments without incurring high infrastructure costs as the user can access the software from any compatible system using an access id or username and password, and that it does not require any complicated installation or implementation. The market is witnessing a shift from on-premise systems to web-hosted deployment of e-prescribing solutions.

On the basis of end user, the hospitals segment is expected to grow at the highest rate during the forecast period. The major factors contributing to the high growth of this segment are the rising adoption rate of the e-prescribing solutions by hospitals in the U.S. and Europe, growing need to improve the profitability of healthcare operations, and growing focus to improve patient safety and advantages of e-prescribing over conventional handwritten prescribing systems. The government initiatives to improve the quality of care delivered to patients and curtailing the soaring healthcare costs are also driving the adoption of e-prescribing solutions in hospitals.

Asia-Pacific possesses lucrative growth potential for the e-prescribing market during the forecast period. The high growth of this region can be attributed to healthcare organizations in the Asia-Pacific region that are actively moving towards digitization with a focus on streamlining their entire workflow and ensuring patient safety, a high share of the geriatric population resulting in significant growth in the prevalence of chronic diseases and increasing the burden of healthcare providers. The hospitals in Japan are widely adopting best practices such as healthcare information exchange, e-prescribing, and electronic health record systems to provide quality care to patients.

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=910

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more